Trial Profile
Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures: a Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jun 2023
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Fracture
- Focus Therapeutic Use
- 30 May 2023 Status changed from active, no longer recruiting to completed.
- 28 Sep 2020 Planned End Date changed from 1 Dec 2021 to 1 Dec 2022.
- 28 Sep 2020 Planned primary completion date changed from 1 Jan 2021 to 1 Dec 2021.